Melody L Lynd, MD
Plastic and Reconstructive Surgery · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 3 carriers
- Office
- 1
- Since medical school
- 33 years
- University of Missouri, Kansas City, School of Medicine, 1993
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
20 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lynd’s office at (408) 871-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G86621 · Current
Licensed to practise in California · since 2002 · expires 2028-04-30 · University of Missouri-Kansas City School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$15,086
Medicare paid this office $15,086 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 17 | $4,074 | $123 |
| New patient visit (45+ min) | 12 | $1,745 | $145 |
Procedures Medicare counted
| Mastectomy | 1-10 | None |
| Melanoma (skin cancer) excision | 19 | More than 74% of doctors who do this |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 74 · Health risk score 1.00. At or below the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: High blood pressure 72%.
The office billed $52,204, Medicare allowed $19,137 and paid $15,086; for 65 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 25 | 65 | 74 | 1.00 | $52,204 | $15,086 |
| 2023 | 27 | 78 | 73 | 0.76 | $70,432 | $18,063 |
| 2022 | 29 | 101 | 74 | 0.70 | $67,566 | $17,806 |
| 2021 | 21 | 70 | 75 | 1.18 | $58,906 | $15,576 |
| 2020 | 22 | 102 | 74 | 1.08 | $75,164 | $18,827 |
| 2019 | 39 | 232 | 75 | 1.69 | $83,587 | $36,407 |
| 2018 | 83 | 629 | 77 | 2.27 | $139,618 | $69,818 |
| 2017 | 68 | 442 | 76 | 2.24 | $103,244 | $55,673 |
| 2016 | 43 | 319 | 72 | 2.09 | $79,011 | $41,629 |
| 2015 | 44 | 238 | 72 | 2.05 | $63,657 | $34,460 |
| 2014 | 45 | 332 | 72 | 2.13 | $75,776 | $42,418 |
| 2013 | 41 | 149 | 75 | 1.40 | $48,292 | $32,084 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 23 | $3,966 | $110 |
| New patient visit (45+ min) | 13 | $2,046 | $157 |
2022: 2 services
| Return visit (30+ min) | 16 | $4,238 | $115 |
| New patient visit (45+ min) | 19 | $2,752 | $145 |
2021: 2 services
| Return visit (30+ min) | 11 | $2,069 | $122 |
| New patient visit (45+ min) | 12 | $1,771 | $148 |
2020: 1 service
| Short return visit (20+ min) | 11 | $1,242 | $73 |
2019: 3 services
| Long return visit (40+ min) | 15 | $2,658 | $121 |
| Short return visit (20+ min) | 12 | $1,693 | $46 |
| Short return visit (20+ min) | 13 | $1,483 | $71 |
2018: 9 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 25 | $12,795 | $128 |
| Short return visit (20+ min) | 35 | $7,718 | $42 |
| New patient visit (60+ min) | 37 | $5,234 | $141 |
| Long return visit (40+ min) | 27 | $4,669 | $120 |
| Application of skin substitute graft to wound of trunk, arms, or legs, 25.0 sq cm or less of wound 100.0 sq cm or less | 12 | $3,062 | $71 |
| New patient visit (60+ min) | 13 | $2,342 | $180 |
| Short return visit (20+ min) | 20 | $2,220 | $62 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $1,154 | $52 |
| Application of chemical to stop tissue regrowth in wound | 15 | $595 | $25 |
2017: 5 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 20 | $8,201 | $128 |
| Short return visit (20+ min) | 24 | $5,166 | $42 |
| New patient visit (60+ min) | 24 | $3,361 | $140 |
| Long return visit (40+ min) | 23 | $3,259 | $121 |
| Short return visit (20+ min) | 18 | $3,159 | $64 |
2016: 6 services
| Short return visit (20+ min) | 21 | $4,465 | $44 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 11 | $3,069 | $133 |
| New patient visit (60+ min) | 19 | $2,732 | $144 |
| Long return visit (40+ min) | 14 | $2,586 | $118 |
| Short return visit (20+ min) | 14 | $2,439 | $66 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $1,870 | $53 |
2015: 5 services
| Long return visit (40+ min) | 18 | $3,993 | $125 |
| New patient visit (60+ min) | 12 | $2,108 | $176 |
| Short return visit (20+ min) | 12 | $1,954 | $42 |
| New patient visit (60+ min) | 13 | $1,850 | $142 |
| Short return visit (20+ min) | 13 | $1,526 | $66 |
2014: 5 services
| Removal of muscle and/or tissue, 20.0 sq cm or less | 14 | $4,879 | $139 |
| Short return visit (20+ min) | 20 | $4,140 | $44 |
| Long return visit (40+ min) | 13 | $3,499 | $125 |
| New patient visit (60+ min) | 12 | $2,143 | $179 |
| New patient visit (60+ min) | 14 | $1,979 | $141 |
2013: 2 services
| Long return visit (40+ min) | 23 | $5,101 | $128 |
| New patient visit (60+ min) | 14 | $2,572 | $184 |
Drugs they prescribed that Part D paid
$177
Pharmacies billed $177 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
28 generic and 0 brand-name prescriptions · $177 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 28 | 11 | None | 0% | $177 |
| 2023 | 17 | None | None | 0% | $123 |
| 2022 | 41 | 12 | None | None | $383 |
| 2021 | 53 | 16 | None | None | $648 |
| 2020 | 22 | None | None | 0% | $358 |
| 2019 | 39 | None | None | 0% | $398 |
| 2018 | 126 | 34 | None | None | $2,414 |
| 2017 | 211 | 39 | 12% (25) | 12% | $14,750 |
| 2016 | 150 | 26 | 15% (23) | 12% | $6,355 |
| 2015 | 134 | 32 | 13% (17) | None | $3,770 |
| 2014 | 161 | 34 | 24% (39) | 7% | $5,435 |
| 2013 | 135 | 24 | 26% (35) | 11% | $2,882 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Amoxicillin-Clavulanate Potass | 11 | $125 | $11 |
2021: 1 drug
| Mupirocin | 12 | $70 | $6 |
2019: 1 drug
| Mupirocin | 12 | $119 | $10 |
2018: 4 drugs
| Mupirocin | 31 | $321 | $10 |
| Sulfamethoxazole-Trimethoprim | 28 | $314 | $11 |
| Amoxicillin-Clavulanate Potass | 16 | $146 | $9 |
| Levofloxacin | 13 | $97 | $7 |
2017: 8 drugs
| Vimpat | 15 | $10,060 | $671 |
| Clopidogrel | 11 | $344 | $31 |
| Mupirocin | 26 | $232 | $9 |
| Amoxicillin-Clavulanate Potass | 18 | $199 | $11 |
| Sulfamethoxazole-Trimethoprim | 21 | $178 | $8 |
| Tramadol | 12 | $159 | $13 |
| Sertraline | 11 | $138 | $13 |
| Enalapril Maleate | 13 | $133 | $10 |
2016: 3 drugs
| Mupirocin | 28 | $269 | $10 |
| Amoxicillin-Clavulanate Potass | 24 | $205 | $9 |
| Tramadol | 11 | $96 | $9 |
2015: 3 drugs
| Gentamicin Sulfate | 11 | $425 | $39 |
| Mupirocin | 23 | $221 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $125 | $11 |
2014: 5 drugs
| Nadolol | 11 | $1,353 | $123 |
| Amox Tr-Potassium Clavulanate | 23 | $348 | $15 |
| Mupirocin | 25 | $290 | $12 |
| Hydrocodone-Acetaminophen | 25 | $233 | $9 |
| Sulfamethoxazole-Trimethoprim | 11 | $39 | $4 |
2013: 2 drugs
| Amox Tr-Potassium Clavulanate | 19 | $288 | $15 |
| Hydrocodone-Acetaminophen | 21 | $166 | $8 |
Money from drug and device companies
$2,500 in 2021
| 2021 | 1 | 1 | $2,500 | $2,500 |
| 2019 | 1 | 3 | None | $600 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Musculoskeletal Transplant Foundation | None | $2,500 | 1 payment
|
See the published payment
| Musculoskeletal Transplant Foundation | Consulting · 2021-04-01 | None | $2,500 |
See earlier years (2019)
2019: $600
| Musculoskeletal Transplant Foundation | None | $600 | 3 payments
|
Professional record
- NPI
- 1730286626
- Licence
- CA G86621California G86621: Current · expires 2028-04-30
- Trained
- University of Missouri, Kansas City, School of Medicine, 1993 · 33 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208200000X (208200000X)
- Mailing address
- 2125 Vizcaya Way, Campbell, CA, 95008
- NPI first listed
- 2006-09-20
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.